Characterization of a presymptomatic stage in a Drosophila Parkinson's disease model: Unveiling dopaminergic compensatory mechanisms.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biochimica et Biophysica Acta - Molecular Basis of Disease

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbadis.2017.07.013PMID 28716706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease

  2017cited by this paper
• Study of the Contribution of Nicotinic Receptors to the Release of Endogenous Biogenic Amines in Drosophila Brain

  2016cited by this paper
• Parkinson's disease

  2015cited by this paper
• Improving l‐dopa therapy: The development of enzyme inhibitors

  2015cited by this paper
• Flies with Parkinson's disease.

  2015cited by this paper
• Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.

  2014cited by this paper
• Serotonin Receptors Expressed in Drosophila Mushroom Bodies Differentially Modulate Larval Locomotion

  2014cited by this paper
• Neuronal glycogen synthesis contributes to physiological aging

  2014cited by this paper
• Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease: a pragmatic approach

  2013cited by this paper
• Impaired Sense of Smell in a Drosophila Parkinson’s Model

  2013cited by this paper
• nAChR‐induced octopamine release mediates the effect of nicotine on a startle response in Drosophila melanogaster

  2013cited by this paper
• Olfactory dysfunction in Parkinson disease

  2012cited by this paper
• Open Source Tracking and Analysis of Adult Drosophila Locomotion in Buridan's Paradigm with and without Visual Targets

  2012cited by this paper
• Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures.

  2011cited by this paper
• Catecholamines up integrates dopamine synthesis and synaptic trafficking

  2011cited by this paper
• Responsiveness to distracting stimuli, though increased in Parkinson's disease, is decreased in asymptomatic PINK1 and Parkin mutation carriers.

  2010cited by this paper
• Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease

  2009cited by this paper
• Mechanisms compensating for dopamine loss in early Parkinson disease

  2009cited by this paper
• NMDA receptors mediate an early up‐regulation of brain‐derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease

  2009cited by this paper
• Enhancing Aromatic L‐amino Acid Decarboxylase Activity: Implications for L‐DOPA Treatment in Parkinson's Disease

  2008cited by this paper
• Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin

  2006cited by this paper
• Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin

  2006cited by this paper
• The correlative triad among aging, dopamine, and cognition: current status and future prospects.

  2006cited by this paper
• Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila

  2006cited by this paper
• Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

  2006cited by this paper
• A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining

  2006cited by this paper
• Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes

  2005cited by this paper
• Rapid iterative negative geotaxis (RING): a new method for assessing age-related locomotor decline in Drosophila.

  2005cited by this paper
• Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes

  2005cited by this paper
• Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.

  2004cited by this paper
• Aging Results in Reduced Epidermal Growth Factor Receptor Signaling, Diminished Olfactory Neurogenesis, and Deficits in Fine Olfactory Discrimination

  2004cited by this paper
• The analog inhibitor, α-methyl dopa, as a screening agent for mutants elevating levels of dopa decarboxylase activity in Drosophila melanogaster

  2004cited by this paper
• Aminergic neurons in the brain of blowflies and Drosophila: dopamine- and tyrosine hydroxylase-immunoreactive neurons and their relationship with putative histaminergic neurons

  2004cited by this paper
• Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.

  2003cited by this paper
• A role for alpha-synuclein in the regulation of dopamine biosynthesis.

  2002cited by this paper
• Prevalence of olfactory impairment in older adults.

  2002cited by this paper
• A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis

  2002cited by this paper
• Dopamine and senescence in Drosophila melanogaster.

  2000cited by this paper
• Differences in locomotor activity across the lifespan of Drosophila melanogaster.

  1999cited by this paper
• Immunochemical analysis of dopamine transporter protein in Parkinson's disease

  1997cited by this paper
• Differential recovery of dopamine synthetic enzymes following MPTP and the consequences of GM1 ganglioside treatment.

  1990cited by this paper

• In Vitro Antioxidant Activity and In Vivo Neuroprotective Effect of Parastrephia quadrangularis in a Drosophila Parkinson’s Disease Model

  2025cites this paper
• Modeling neurodegeneration and neuroinflammation in Parkinson's Disease: Animal-based strategies.

  2025cites this paper
• Using Single-Cell RNA sequencing with Drosophila, Zebrafish, and mouse models for studying Alzheimer's and Parkinson's disease.

  2025cites this paper
• Exploring the versatility of Drosophila melanogaster as a model organism in biomedical research: a comprehensive review

  2024cites this paper
• Kanamycin treatment in the pre-symptomatic stage of a Drosophila PD model prevents the onset of non-motor alterations.

  2023cites this paper
• Drosophila olfaction as a model system for studying human neurological disorders

  2023cites this paper
• Developmental exposure to the Parkinson’s disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice

  2023cites this paper
• Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment

  2023cites this paper
• An Early Disturbance in Serotonergic Neurotransmission Contributes to the Onset of Parkinsonian Phenotypes in Drosophila melanogaster

  2022cites this paper
• Exploring the link between Parkinson’s disease and Diabetes Mellitus in Drosophila

  2022cites this paper
• Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila

  2022cites this paper
• Exploring therapeutic potential of mitophagy modulators using Drosophila models of Parkinson’s disease

  2022cites this paper
• Parkin Knockdown Modulates Dopamine Release in the Central Complex, but Not the Mushroom Body Heel, of Aging Drosophila.

  2022cites this paper
• Nicotine suppresses Parkinson’s disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels

  2021cites this paper
• Assessing olfactory, memory, social and circadian phenotypes associated with schizophrenia in a genetic model based on Rim

  2021cites this paper
• Dop1R1, a type 1 dopaminergic receptor expressed in Mushroom Bodies, modulates Drosophila larval locomotion

  2020cites this paper
• RING Finger Protein 11 (RNF11) modulates dopamine release in Drosophila

  2020cites this paper
• Study of the release of endogenous amines in Drosophila brain in vivo in response to stimuli linked to aversive olfactory conditioning

  2020cites this paper
• The behavioral and neurochemical characterization of a Drosophila dysbindin mutant supports the contribution of serotonin to schizophrenia negative symptoms.

  2020cites this paper
• Modeling Neurodegenerative Disorders in Drosophila melanogaster

  2020cites this paper
• Drosophila as a Model System for Neurotransmitter Measurements.

  2018cites this paper
• Unveiling the Dual Role of the Dopaminergic System on Locomotion and the Innate Value for an Aversive Olfactory Stimulus in Drosophila.

  2018cites this paper
• Novel models for Parkinson’s disease and their impact on future drug discovery

  2018cites this paper
• Electrochemistry in and of the Fly Brain

  2018cites this paper